Dr. Vivek Yarlagadda, MD

Dr. Yarlagadda practices at CommonSpirit - St. Anthony North Hospital in Westminster, Colorado, part of CommonSpirit Health.

Dr. Yarlagadda's NPI, 1669836854, was assigned on April 13, 2016. Dr. Yarlagadda holds Wyoming license 11733A.

Dr. Yarlagadda's primary practice is CommonSpirit - St. Anthony North Hospital, at 14300 Orchard Pkwy, Westminster, CO 80023 in Broomfield County. The practice phone is (720) 627-0000.

Dr. Yarlagadda's primary practice is CommonSpirit - St. Anthony North Hospital in Westminster, Colorado, part of CommonSpirit Health. The medical group on file is Colorado Permanente Medical Group. Dmand AI also links Dr. Yarlagadda to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Yarlagadda practices. Vendor and product names are available with a free account.

Internal medicine is Dr. Yarlagadda's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Yarlagadda is licensed in Wyoming.

CMS data shows 429 Medicare services from Dr. Yarlagadda across 5 procedure codes in 2024, for 186 Medicare patients. Medicare paid $37,704 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 186 Medicare patients who saw Dr. Yarlagadda in 2024. The largest group is 75 to 84, with 73 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.90, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Yarlagadda's median patient age at 65, with 65% women.

In 2024, Dr. Yarlagadda wrote 198 Medicare Part D claims for 59 patients. 91% of them were for generic drugs. CMS names the drug for 40 of them, across 2 drugs with 11 or more claims each, at $268 in total drug cost. In 2023, CMS named 67 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Yarlagadda for performance year 2024, reported through an alternative payment model (APM). Dr. Yarlagadda accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to Dr. Yarlagadda from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. ITI, Inc. paid the most, $28.